56
Participants
Start Date
February 1, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
HK-001
HK-001 is synthesized by PharmaCore Biotech Co., Ltd. Synthetic (Z)-BP with high purity will be used in this proposed study.
Placebo control
In order to evaluate the safety and tolerability of HK-001 more accurately, a drug-free placebo control is planned to be utilized for the same administration route in this proposed trial. The placebo control that is identical in appearance, smell, weight, and excipients will be supplied by Everfront Biotech Inc.
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien City
Everfront Biotech Co., Ltd.
INDUSTRY